AtheroGenics Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 0.0 | 52.3 | 31.7 |
| Cost of Goods Sold | 0.0 | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 10.4 | 13.9 | 13.4 |
| Depreciation & Amortization | 4.5 | 2.6 | 1.0 |
| Operating Income | -- | -- | -- |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | (20.8) | 0.0 | (3.5) |
| Nonoperating Expenses | (7.8) | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (64.2) | (49.5) | (67.3) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (64.2) | (49.5) | (67.3) |
| Total Net Income | (64.2) | (49.5) | (67.3) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.62) | (1.25) | (1.71) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
